Miriam Zimmermann

5PUBLICATIONS
26CO-AUTHORS
Rheumatology and arthritisApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Psychological methodology, design and analysisAllergyPsychopharmacology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 01, 2025
Validity and Psychometric Properties of 3 and 4 Visual Analog Scale in Participants With Psoriatic Arthritis Treated With Guselkumab.

William Tillett, Laura C Coates, Marijn Vis

|Dec 13, 2024
Sustained response to guselkumab regardless of baseline characteristics in patients with active psoriatic arthritis and inadequate response to TNF inhibitors: results from the phase 3b COSMOS clinical trial.

Iain B McInnes, Philipp Sewerin, Mohamed Sharaf

|Mar 26, 2024
Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study.

Laura C Coates, Laure Gossec, Miriam Zimmermann

|Jan 22, 2024
Modulation of Interleukin-23 Signaling With Guselkumab in Biologic-Naive Patients Versus Tumor Necrosis Factor Inhibitor-Inadequate Responders With Active Psoriatic Arthritis.

Stefan Siebert, Laura C Coates, Georg Schett

|Mar 31, 2023
Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA.

Pascal Richette, Marijn Vis, Sarah Ohrndorf

Pageof 1

Frequent Collaborators

4 joint publications

Laura C Coates

2 joint publications

Peter Nash

2 joint publications

William Tillett

2 joint publications

Philip S Helliwell